By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131




Metabasis Therapeutics, Inc.  – Hepatitis B

Company News
No Worries, Bayer (BAY) Snubs Zoetis (ZTS) But Valeant (VRX) Still Looking 7/2/2015 6:28:17 AM
Valeant (VRX) Reportedly Makes Bid for Zoetis (ZTS) in "Mega Deal" 6/26/2015 7:21:20 AM
Valeant (VRX) To Announce 2015 Second Quarter Results On July 23, 2015 6/24/2015 10:38:11 AM
Valeant (VRX) and Progenics Pharmaceuticals, Inc. (PGNX) Announce the Submission of U.S. New Drug Application for Oral RELISTOR 6/23/2015 7:44:15 AM
Valeant (VRX) Taps M&A Expert as New CFO As Dealmaking Roars 6/11/2015 7:28:28 AM
Valeant (VRX) Release: RELISTOR Receives European Approval For Expanded Indication To Treat All Opioid-Induced Constipation 6/3/2015 7:24:14 AM
Actavis (ACT), Valeant (VRX) Win FDA Approval for VIBERZI to Treat IBS With Diarrhea 5/28/2015 5:34:07 AM
Valeant (VRX) Chief Calls Recent Biotech M&A "Bit of a Bubble" 5/22/2015 9:57:29 AM
Valeant (VRX) Announces 2015 Annual Meeting Results 5/20/2015 7:06:05 AM
Valeant (VRX) in Talks to Pay $700 to $800 Million for Egyptian Drugmaker Amoun to Expand GI Line 5/20/2015 6:16:19 AM